Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells. [electronic resource]
Producer: 20170209Description: 10257-67 p. digitalISSN:- 1423-0380
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Benzamides -- pharmacology
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colorectal Neoplasms -- pathology
- Enzyme-Linked Immunosorbent Assay
- Flow Cytometry
- Gene Knockdown Techniques
- Histone Deacetylase Inhibitors -- pharmacology
- Humans
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.